Semi-Annual Consolidated Statement Of Income

K Pharma,Inc. - Filing #7311570

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Semi-annual consolidated statement of income
Statement of income
Net sales
JPY
1,000,000,000 JPY
Cost of sales
JPY
90,000,000 JPY
Ordinary profit (loss)
-422,670,000 JPY
651,026,000 JPY
Gross profit (loss)
JPY
910,000,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
51,600,000 JPY
36,200,000 JPY
Taxes and dues
468,000 JPY
24,094,000 JPY
Selling, general and administrative expenses
423,489,000 JPY
258,890,000 JPY
Extraordinary losses
2,677,000 JPY
36,497,000 JPY
Profit (loss) before income taxes
-425,347,000 JPY
614,528,000 JPY
Operating profit (loss)
-423,489,000 JPY
651,109,000 JPY
Income taxes - current
1,157,000 JPY
99,755,000 JPY
Non-operating income
Interest income
14,000 JPY
7,000 JPY
Non-operating income
819,000 JPY
7,000 JPY
Non-operating expenses
Non-operating expenses
JPY
90,000 JPY
Income taxes
1,157,000 JPY
99,755,000 JPY
Profit (loss)
-426,505,000 JPY
514,772,000 JPY
Extraordinary losses
Impairment losses
2,677,000 JPY
36,497,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.